Zacks Research Brokers Lower Earnings Estimates for Amdocs

Amdocs Limited (NASDAQ:DOX) – Zacks Research lowered their Q2 2026 earnings per share estimates for Amdocs in a research note issued on Tuesday, February 24th. Zacks Research analyst Team now expects that the technology company will post earnings per share of $1.50 for the quarter, down from their prior estimate of $1.60. The consensus estimate for Amdocs’ current full-year earnings is $6.21 per share. Zacks Research also issued estimates for Amdocs’ Q3 2026 earnings at $1.68 EPS, Q4 2026 earnings at $1.77 EPS, FY2026 earnings at $6.56 EPS, Q1 2027 earnings at $1.69 EPS, Q2 2027 earnings at $1.73 EPS, Q3 2027 earnings at $1.79 EPS, Q4 2027 earnings at $1.83 EPS and FY2027 earnings at $7.04 EPS.

Amdocs (NASDAQ:DOX) last issued its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. During the same period in the prior year, the company earned $1.66 earnings per share. The firm’s revenue was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS.

Several other brokerages have also weighed in on DOX. Stifel Nicolaus dropped their target price on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Bank of America reduced their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Amdocs presently has an average rating of “Moderate Buy” and an average price target of $92.33.

Amdocs Stock Up 5.1%

Shares of Amdocs stock opened at $69.86 on Friday. The stock has a market capitalization of $7.54 billion, a price-to-earnings ratio of 13.51, a PEG ratio of 1.18 and a beta of 0.40. Amdocs has a twelve month low of $65.74 and a twelve month high of $95.41. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. The business’s 50 day simple moving average is $77.84 and its 200-day simple moving average is $80.68.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a yield of 3.3%. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. Amdocs’s dividend payout ratio is 40.81%.

Institutional Trading of Amdocs

Large investors have recently modified their holdings of the company. Pzena Investment Management LLC boosted its holdings in Amdocs by 82.6% during the fourth quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock valued at $969,100,000 after acquiring an additional 5,443,766 shares during the period. LSV Asset Management lifted its position in shares of Amdocs by 0.8% in the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock worth $296,159,000 after acquiring an additional 29,829 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in shares of Amdocs by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock worth $253,786,000 after purchasing an additional 54,676 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Amdocs by 3.0% in the third quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock valued at $258,583,000 after purchasing an additional 91,900 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in Amdocs by 0.3% during the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after buying an additional 9,207 shares in the last quarter. 92.02% of the stock is owned by institutional investors.

Key Amdocs News

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Zacks Research raised multiple quarterly and full‑year EPS forecasts — including FY2027 to $7.04 (from $6.92) and FY2026 to $6.56 (from $6.48) — reflecting stronger expected earnings across 2026–2027. This aggregate upward revision is the primary bullish driver behind the stock move today.
• Positive Sentiment: Zacks also bumped several individual quarter estimates (examples: Q4 2026 to $1.77, Q3 2027 to $1.79, Q4 2027 to $1.83 and Q1 2028 to $1.82) and raised FY2028 to $7.55, signaling improving longer‑term visibility for Amdocs’ revenue/profitability trajectory.
• Neutral Sentiment: Zacks published a style/coverage piece calling Amdocs a “Top‑Ranked Growth Stock,” which can attract attention from growth‑focused investors but is more descriptive than news‑driving. Amdocs (DOX) is a Top-Ranked Growth Stock: Should You Buy?
• Neutral Sentiment: Short‑interest reports for late February show values of “0 shares” and NaN changes — this appears to be a reporting anomaly and provides no meaningful bearish signal to investors at this time.
• Negative Sentiment: Offsetting some positives, Zacks trimmed its Q2 2026 estimate to $1.50 from $1.60, which may reflect expected near‑term softness or timing of revenue recognition and could cap upside until that quarter passes.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.